Kadimastem Ltd Cash Flow Conversion Efficiency

Latest as of June 2023: -21.633x

Kadimastem Ltd cash flow conversion efficiency. Based on the latest financial reports, Kadimastem Ltd (KDST) has a cash flow conversion efficiency ratio of -21.633x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-3.66 Million ≈ $-9.80K USD) by net assets (ILA169.00K ≈ $453.08 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kadimastem Ltd (2013–2024)

Cash flow conversion efficiency of Kadimastem Ltd from 2013 to 2024. This chart illustrates how Kadimastem Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View KDST share price today for real-time trading data and today's change.

Kadimastem Ltd Cash Flow Conversion Ratio Explained

Kadimastem Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kadimastem Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kadimastem Ltd ranked by their cash flow conversion efficiency. Also see Kadimastem Ltd (KDST) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Renewables Infrastructure Grp LSE:TRIG	0.022x
Lithium Energy Ltd AU:LEL	-0.041x
Hitechpros PA:ALHIT	0.017x
SUNEX S.A. WAR:SNX	0.051x
RTA Laboratuvarlari Biyolojik IS:RTALB	0.010x
Data I/O Corporation NASDAQ:DAIO	-0.025x
Golden Heaven Group Holdings Ltd. Ordinary Shares NASDAQ:GDHG	0.020x
Innature Bhd KLSE:5295	-0.063x

Annual Cash Flow Conversion Efficiency for Kadimastem Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Kadimastem Ltd from 2013 to 2024. Review financial agility of Kadimastem Ltd to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA-29.15 Million ≈ $-78.14K	ILA-2.75 Million ≈ $-7.39K	0.095x	-96.28%
2023-12-31	ILA-4.36 Million ≈ $-11.69K	ILA-11.09 Million ≈ $-29.72K	2.543x	+104.15%
2022-12-31	ILA326.00K ≈ $873.99	ILA-20.00 Million ≈ $-53.61K	-61.337x	-4278.97%
2021-12-31	ILA15.38 Million ≈ $41.24K	ILA-21.55 Million ≈ $-57.76K	-1.401x	-151.79%
2020-12-31	ILA-8.06 Million ≈ $-21.61K	ILA-21.80 Million ≈ $-58.45K	2.704x	+53.93%
2019-12-31	ILA-12.03 Million ≈ $-32.24K	ILA-21.13 Million ≈ $-56.64K	1.757x	+156.84%
2018-12-31	ILA6.74 Million ≈ $18.06K	ILA-20.83 Million ≈ $-55.84K	-3.091x	+33.28%
2017-12-31	ILA4.28 Million ≈ $11.47K	ILA-19.83 Million ≈ $-53.16K	-4.633x	-390.73%
2016-12-31	ILA-8.56 Million ≈ $-22.94K	ILA-13.63 Million ≈ $-36.55K	1.594x	-85.47%
2015-12-31	ILA-1.02 Million ≈ $-2.74K	ILA-11.22 Million ≈ $-30.08K	10.967x	+273.45%
2014-12-31	ILA1.55 Million ≈ $4.15K	ILA-9.78 Million ≈ $-26.22K	-6.323x	-241.15%
2013-12-31	ILA7.28 Million ≈ $19.50K	ILA-13.48 Million ≈ $-36.15K	-1.853x	--

About Kadimastem Ltd

TA:KDST Israel Biotechnology

Market Cap

$22.18 Million

ILA8.27 Billion ILA

Market Cap Rank

#24647 Global

#353 in Israel

Share Price

ILA2794.00

Change (1 day)

+0.00%

52-Week Range

ILA2794.00 - ILA2794.00

All Time High

ILA78228.15